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David A. Wise 
This volume contains papers presented at a  joint JCER-NBER conference 
held in Nikko, Japan in March 2003. It is the fifth in a series of JCER- 
NBER projects comparing aspects of the economic systems and economic 
behavior in the United States and Japan. The previous volumes are Aging 
in the  United States and Japan: Economic Trends (1994), The Economic 
Efects of Aging in the United States and Japan (1  997), Aging Issues in the 
United States and Japan (2001), and Labor Markets and Firm BeneJt Poli- 
cies in Japan and the United States (2003). The papers in this volume direct 
attention to the health care systems in the two countries. 
Recent data compiled by the Organization for Economic Cooperation 
and Development (OECD) in OECD  Health Data 2005 highlights signifi- 
cant differences in health and health care between Japan and the United 
States. For instance, among OECD countries, Japan spends close to the 
lowest percentage of its gross domestic product (GDP) on health care (7.9 
percent), while the United States spends the highest (15 percent). Yet life 
expectancies in Japan are the longest in the world-eighty-two  years (at 
birth), compared with seventy-seven years in the United States. Interest- 
ingly, despite its lower spending on health care, Japan has many more hos- 
pital beds per capita (8.5 per thousand population compared with 2.8 per 
thousand in the United States), more computed tomography (CT) scan- 
ners (93 per million in Japan compared with 13 per million in the United 
States), and more magnetic resonance imaging (MRT) machines (35 per 
million in Japan compared with 9 per million in the United States). Japan 
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has the lowest obesity rate among OECD countries (3 percent), while the 
United States has the highest (31 percent). At the same time, smoking rates 
in Japan are nearly double those in the United States (over 30 percent in 
Japan, and 17 percent in the United States). Eighty-two percent of health 
care spending in Japan is public spending, compared with 44 percent in the 
United States. These OECD summary measures, and many others, raise all 
kinds of questions about how the health care systems operate differently in 
the two countries and how these operational differences relate to health 
care quality, costs, and outcomes. 
The goals of this volume (and the NBER-JCER  project more generally) 
are not to replicate these comparative statistics, but rather to explore the 
structural characteristics of the health care systems in each country, the 
economic incentives underlying the systems, and how they operate in prac- 
tice. In both countries the rising cost of health care presents important fi- 
nancial challenges. Indeed, aging populations and rising health care costs 
are motivating health system reform throughout the world. The intention 
of this effort was to begin an assessment of the health care systems in Japan 
and the United States, with the hope that a better understanding of ele- 
ments of both systems could lead to improvements in both. The papers 
have not been selected to provide a systematic or comprehensive compari- 
son of care in the two countries, although with respect to some issues such 
comparisons are made. Instead the goal is to explore in greater depth se- 
lected aspects of each health care system. The studies are topical investi- 
gations that can serve as background to more comprehensive and direct 
comparative work. 
The volume is organized in three major sections. The first includes stud- 
ies of the health care systems in Japan and the United States and how those 
systems are evolving with the financial pressures of rising health care costs. 
The second major section includes studies on the variations in medical 
practice patterns and quality of care in the two countries. A final section 
addresses selected other health care topics in Japan and the United States. 
Together, the ten studies offer valuable insight into the differences  in health 
care systems in the two countries. This summary draws heavily on the au- 
thors’ own words. 
The Health Care Systems in Japan and the United States 
Four  papers direct  attention  to the  structural  characteristics  of  the 
health care systems in Japan and the United States, the financial challenges 
posed by  an aging population and rising costs, and the impact of these 
financial pressures on health system reform. How does each country ad- 
dress the basic issues of health insurance coverage, access to care, and fi- 
nancing? And in what ways are the health systems and policies evolving in 
response to the common pressures of older populations and rising costs? Introduction  3 
In “Evaluating Japan’s Health Care Reform of the 1990s and Its Effects 
to Cope with Population Aging,” Naohiro Yashiro, Reiko Suzuki, and 
Wataru Suzuki examine the basic structure of the Japanese medical care 
system, focusing primarily on recent policy issues. Their paper reviews re- 
cent  demographic  developments  in  light  of  policy  and  institutional 
changes in Japan’s health care system in the 1990s. The authors estimate 
the quantitative effects of the recently proposed institutional changes in 
health insurance schemes and show that they have only short-term effects 
in improving the fiscal balances in the system. 
As background, the paper discusses Japan’s generous health insurance 
schemes, under which all citizens, including the self-employed, are sup- 
posed to have some form of health insurance. Japan guarantees patients 
“free access” to hospitals with no gatekeepers and provides certain med- 
ical services under a “fee-for-service’’ health insurance arrangement. The 
authors point out that such generous access aggravates the financial chal- 
lenges of population aging. Thus the effect of population aging is already 
reflected in growing fiscal deficits in health insurance budgets that are bur- 
dened by an increasing number of elderly enrollees, who are heavy users of 
health resources. Given the generous access to care and the limited finan- 
cial incentive for cost-effective health care decision making, the authors 
are surprised that Japan’s national health expenditures have remained at a 
relatively low level. 
One interpretation of the combination of low costs and generous access 
is that Japan has maintained relatively low physician salaries. The system 
also has been efficient in providing basic health care services to the popu- 
lation as a whole, reflecting people’s strong preference for egalitarian ac- 
cess in Japan. With the aging of the population, however, the major burden 
of disease has shifted from infectious and acute diseases to chronic disease. 
This reduces the positive externalities of medical treatments as well as the 
extent of the asymmetry of information between providers and patients. 
Also, the preferences of patients have shifted toward better quality health 
services with  medical  information. It is  against  this  background  that 
changes in the Japanese health care system are considered. 
The health system in Japan has many features in common with the Medi- 
care program for the elderly in the United States. The question of how to 
reform the current welfarelike health scheme in Japan has much in com- 
mon with U.S. Medicare reform. The major reform proposals include stan- 
dardization of medical treatments, partial replacement of public health in- 
surance with private health insurance, introduction of a partial managed 
care system, and introduction of for-profit hospitals to stimulate competi- 
tion. 
The authors find that various policy reforms introduced in the 1990s did 
not effectively solve the fundamental problems. For example, the expan- 
sion of long-term care insurance in 2000 was intended to move care for the 4  David A. Wise 
frail elderly from costly hospitals to nursing homes, but the effect has been 
marginal, with free access to hospitals basically maintained. Another re- 
form was raising the copayment rate and redistributing costs among vari- 
ous insurance providers, though the positive fiscal impacts of these reforms 
is projected to last only over the short run. The 2003 health insurance re- 
form is a first step toward a more comprehensive reform of the health care 
services sector, the authors conclude. 
The next two papers in the volume address some of the same general is- 
sues that are addressed in the Yashiro, Suzuki, and Suzuki chapter, but 
with a focus on the United States health care system and on the health sys- 
tems of OECD countries more generally. “The U.S. Medical Care System 
for the Elderly” characterizes the health care system in the United States, 
while “An International Look at the Medical Care Financing Problem” 
considers the financing challenges posed by population aging and rising 
health care costs, how health systems may continue to evolve going for- 
ward, and the extent to which health care costs are likely to continue to in- 
crease into the future. 
In “The U.S. Medical Care System for the Elderly,” David Cutler and I 
examine the structure of the American medical care system, especially the 
system of care for the elderly. We focus on three sets of interactions: cover- 
age rules (how people get health insurance and who pays for it), the re- 
imbursement system (how providers are paid), and access rules (what are 
the financial and nonfinancial barriers to receipt of care). 
We note that Medical care systems are multidimensional, and so our de- 
scription must be as well. The basis for our analysis is the medical care 
triad. There are three participants in the medical care system: patients, 
providers, and insurers. Patients pay money to insurers (either directly or 
indirectly, as we discuss in the following) and pay for some care directly. In- 
surers reimburse providers for care and set rules under which the care can 
be provided. Providers diagnose and treat patients. 
Corresponding to these three participants are three sets of interactions. 
The first is coverage rules. This encompasses the mechanisms by  which 
people get health insurance and who pays for that insurance. The second 
interaction is the reimbursement system between insurers and providers- 
how is payment determined and what rates are paid? Finally, there are the 
access rules-which  providers are patients allowed to see and under what 
circumstances? In this paper, we  describe the insurance, reimbursement, 
and access rules in the American medical care system. We present broad 
outlines of the system for everyone in the United States. Because the sys- 
tem is so heterogeneous, we focus particular attention on the system for the 
elderly. We note where research has explored a link between system provi- 
sions and outcomes, but we do not take the further step of relating system 
provisions to health outcomes in any systematic way. Introduction  5 
While there is variability even within the United States, we  suggest the 
following simple summary. Coverage in the United States is spotty-ex- 
cellent for the elderly, but not guaranteed for the nonelderly. Historically, 
reimbursement of providers was very generous, and access was open as 
well. Increasingly, though, the reimbursement and access routes are being 
restricted as insurers respond to moral hazard and the demand for cost 
containment. 
The direction the medical system will go in the United States is not clear. 
Even in the past few years, reimbursement and access rules have changed, 
and coverage issues have dominated the public agenda. Changes along all 
three dimensions bear watching. We emphasize that it is also important to 
extend this analysis to other countries. By characterizing existing systems 
and comparing outcomes across countries, we can use the cross-national 
perspective to inform the evolution of health policy and health systems 
within countries. Some cross-national perspective is provided in the next 
chapter, which considers the challenges of medical care financing in all 
OECD countries. 
In “An International Look at the Medical Care Financing Problem,,’ 
David Cutler notes that, as populations age and medical spending rises, 
medical systems will account for an increasing part of economic activity. 
Virtually all developed countries are worried about how to finance medical 
care. Medical costs are increasing more rapidly than tax revenues to pay 
for them, and populations are aging, each of which increases the burden on 
the public sector. In the United States, we speak of a “Medicare crisis” and 
a “Social Security crisis,” where the government will no longer be able to 
meet its health care bills. Other countries refer to “aging crisis” or an “old 
age insurance crisis.” 
Given that medical care costs are certain to rise, Cutler asks how much 
the increase will be and what magnitude of reform will be needed to meet 
the needs. To answer these questions, he develops a forecast model of med- 
ical spending in OECD countries that uses as inputs current spending on 
medical care and the demographic mix of the population as it stands now 
and as it is expected to change. The model estimates the share of medical 
spending in GDP  in the future. Because most countries pay for the bulk of 
medical services publicly, this forecast is closely related to the increase in 
the public-sector financing burden that can be expected. 
The results yield several important conclusions. First, all OECD coun- 
tries can expect an increase in the cost of medical care over time. On the ba- 
sis of demographic change alone, the typical country can expect medical 
care to increase by 2.2 percent of GDP in the next thirty years and by 3.6 
percent of GDP in the next half century. Including continued technologi- 
cal innovation in medicine at the rate experienced in the past raises the pro- 
jected increase in the next thirty years to 5.7 percent of GDP. Interestingly, 6  David A. Wise 
the data suggest that the medical care problem is about equally split be- 
tween the consequences of aging and the consequences of technological 
change in medical treatments. 
The coming medical care burden differs substantially across countries. 
The countries that will be hardest hit by demographic change are Spain, 
Switzerland, the Czech Republic, Italy, and Greece. All of these countries 
have very low fertility rates and large projected increases in life expectancy. 
Demographic change will raise medical spending in these countries by 5 to 
6 percent of GDP. Japan and the United States rank in the middle of this 
scale, 9th and 12th, respectively, out of twenty-nine countries (expected in- 
creases of 4.4 and 3.7 percent), while Turkey, the United Kingdom, New 
Zealand, and Mexico are among the countries least affected, with expected 
increases of 2 percent or less. 
Accounting for technological change has a material impact on these 
rankings. Most importantly, it raises the financing burden in the United 
States. The United States spends more than other countries do on medical 
care and has the most technologically advanced medical system. Thus, if 
technology increases costs at the same rate everywhere, the United States 
will be particularly hard hit. Using historical growth rates of medical costs 
as a guide to the future, the projected increase in medical spending in the 
United States over the next thirty years is close to 10 percent. The increase 
in Japan will be more than 6 percent of GDP. 
These are sizeable estimates, although perhaps not cataclysmic, Cutler 
concludes. He shows, however, that affording such increases will require re- 
ductions in the growth of nonmedical consumption, but not absolute de- 
clines in the level of such spending. 
The next chapter in the volume considers the distribution of health care 
costs and health care use by age in Japan, the extent to which costs are 
cross-subsidized across age groups and across segments of the health fi- 
nancing system, and how recent and prospective health system reforms 
may affect this cross-subsidization. It enhances our understanding of the 
components of health care finance in Japan, and how the components in- 
teract in support of the overall health care system in Japan. 
In “Removing the Instability and Inequity in the Japanese Health In- 
surance System” Seiritsu Ogura, Tamotsu Kadoda, and Makoto Kawa- 
mura compare Japan’s current public medical insurance to an unstable 
two-story building, whose second floor (health insurance for the elderly) is 
becoming heavier each day, while its first floor is losing strength. There are 
three pillars in the first floor that support the weight of the whole building. 
These are (1) insurance programs that cover the health care costs of em- 
ployees and their dependents,  (2) National Health Insurance programs 
(NH1s)-primarily  more than 3,200 municipal programs-that  provide 
insurance to self-employed workers, retirees, and others who are not cov- 
ered by employees’ programs, and (3) subsidies from the national and mu- Introduction  7 
nicipal governments. Each of these supports is funded in a different way. 
The employees’ programs charge different premiums depending on the 
program, but collect far more revenue than necessary to pay their benefits. 
The NHIs, on the other hand, are financially weak and, like the programs 
for the elderly, depend on generous government subsidies. 
The second floor of the building consists of health care insurance for the 
elderly, which provides medical care benefits to those over seventy for very 
little cost. Because this program does not collect premiums on its own, the 
benefits are paid by collecting charges from the “first-floor’’ public insur- 
ance programs. Thus, most of the health care costs of the elderly have been 
shifted from the employees’ health insurance programs and the national 
government. Under the current system, 70 percent of the health care costs 
of the elderly (net of their small out-of-pocket costs) are charged to these in- 
surance programs, with each program contributing an amount in propor- 
tion to the number of its insured individuals and the average health care cost 
of elderly in the system. Of the remaining 30 percent, the national govern- 
ment contributes 20 percent and local governments contribute 10 percent. 
This two-story structure, the authors say, has become very unstable for 
two reasons, one cyclical and the other structural. Japan’s prolonged eco- 
nomic slump over the past decade has had a large negative effect on the rev- 
enues of all the insurance programs in the first floor. In addition, the rapid 
increase in the number of individuals who are reaching age seventy adds a 
significant weight to the second floor while removing support from the 
first. 
Given the current two-story system, the bulk of the increase in health 
care costs of the elderly has been absorbed by increases in employee insur- 
ance premiums and budget deficits. Employees’ out-of-pocket costs have 
been raised in steps, from 10 percent to 20 percent in 1997, and from 20 
percent to 30 percent in 2003 for employees, and from 20 percent to 30 per- 
cent for their dependents. These changes have left employees on par with 
individuals covered by NHIs as far as the out-of-pocket costs are con- 
cerned, while increasing premiums by a factor of two. Similarly, the gov- 
ernment has to deal with the swelling need for subsidies and the deepening 
of the budget deficit amidst a rapid decline in tax revenues. 
The analyses in this paper address what the authors consider to be the 
two major weaknesses in the Japanese health insurance system. The au- 
thors examine the consequences of the “special” treatment of the elderly 
and conclude that it will be difficult to continue to support the elderly at 
current levels. The authors also emphasize that strengthening the financial 
base of the NHI system is a critical part of reforming the health insurance 
system for the elderly. 
Ogura, Kadoda, and Kawamura’s analysis is based on a microsimula- 
tion model, which is used as a tool for judging the properties of a given 
health insurance system. This model consists of a large number of individ- 8  David A. Wise 
ual households that collectively represent the economic and health statis- 
tics of the Japanese economy. The purpose of the simulations was to find 
a scenario under which an employee in his or her working prime (i.e., a 
household head age forty to sixty-four), who may be supporting children, 
would have a financial burden appropriate to the benefits he or she re- 
ceives. The authors find systems that they believe would meet these goals. 
These systems would make the elderly responsible for a larger fraction of 
health care costs than they now pay. By replacing the current system with 
a consumption tax to finance health insurance benefits, it is also possible, 
the authors conclude, to reduce the large disparity in the contribution-to- 
cost ratios across different age groups and improve the vertical equity of 
the medical insurance system. 
Practice Patterns and Quality of Care 
The next four papers consider differences in medical practice patterns 
and quality of care issues in the United States and Japan. While the stud- 
ies focus narrowly on individual diagnoses or other aspects of the health 
care system, rather than on broad cross-national comparative analyses of 
quality, they provide important insights on selected dimensions of quality 
in both countries. For example, the first paper looks at the effects of a hos- 
pital’s volume of angioplasty procedures on outcomes among acute my- 
ocardial infarction (AMI), or heart attack, patients in Japan. The second 
looks at the effects of market concentration on quality among home health 
care delivery services in Japan. The third compares how AM1 patients are 
treated in Japan and the United States. And the fourth looks at the dra- 
matic  variation  in  treatment  patterns  across  geographic  regions  even 
within the United States and what this suggests about the quality of care in 
different places. Together, these studies highlight the value of  studying 
medical practice patterns  in different countries,  as well  as across geo- 
graphic regions within countries, as a statistical basis for evaluating and 
improving quality. 
In “The Volume-Outcome Relationship in Japan: The Case of Percuta- 
neous Transluminal Coronary Angioplasty (PTCA) Volume on Mortal- 
ity of Acute Myocardial Infarction (AMI) Patients,” Koichi Kawabuchi 
and Shigeru Sugihara examine the relationship between the number of per- 
cutaneous transluminal coronary  angioplasty  (PTCA) procedures per- 
formed and negative medical outcomes among AM1 patients in Japan. 
A common presumption is that as the number of procedures increases, 
the quality will improve due to the learning-by-doing (or “practice makes 
perfect”) effect. The authors refer to an inverse relationship between vol- 
ume and negative medical outcomes as a “volume effect.” Hospitals in Japan 
generally perform limited numbers of PTCA procedures each year. Nearly Introduction  9 
half of the hospitals performed fewer than 50 PCTA procedures per year, 
while only 15 percent of the hospitals performed more than 200 (the mini- 
mum  number  recommended  by  the  American  College  of  Cardiology/ 
American Heart Association). Hospitals with more than 400 PTCA pro- 
cedures are quite rare in Japan. 
This paper examines empirically the relationship between volume and 
quality among PTCA procedures in Japan. The authors also investigate the 
nature and channels of this effect, which have implications for reimburse- 
ment policy as well as competition policy. If there is a strong volume effect, 
policies should favor the concentration of PTCA procedures in a small 
number of hospitals or physicians. If this is not the case, policies favoring 
concentration of PTCA procedures may be inappropriate. 
The main conclusions are as follows: (a) The volume effect operates not 
at the hospital level but at the physician level, (b) the volume effect is non- 
linear. Under a specific estimation specification, volumes above a certain 
level result in worse outcomes, so too much is as bad as too little, (c) risk 
adjustment is essential for the evaluation of the quality of health care, as 
risk factors such as shock and multiple occlusions vary considerably across 
physicians and hospitals, and (d) there are virtually no spillover effects and 
no independent organizational influence. The implication is that physi- 
cians learn by themselves. This does not necessarily mean that there is no 
role for peer groups, teamwork, mentors, and so on. Presumably, the au- 
thors say, it simply means that these effects are independent of volume. 
In “Market  Concentration,  Efficiency, and Quality  in  the  Japanese 
Home Help Industry,” Yanfei Zhou and Wataru Suzuki consider the effect 
of market concentration on the quality and cost of home help services. The 
authors point out that until quite recently the family network played the 
primary role in providing care for the frail elderly. However, changes in 
the social structure, such as weakening community ties, a cultural redefin- 
ition of  the family nucleus, and an increasing number of women in the 
workforce, have raised both the financial and psychological burdens of 
family-based care for the aged. 
In response to the expanding elderly population and the increasing de- 
mand for community-based-long-term  care services, the Public Nursing 
Insurance Act (Kaigo Hoken Ho)  was formally enacted in September 1997. 
Under  this  legislation,  the  Ministry  of  Health,  Labor  and  Welfare 
(MHLW) introduced  a new public long-term care insurance system in 
April 2000. This new system aims to respond to society’s major concerns 
about aging and to assure citizens that they will receive care, if necessary, 
and be supported by society as a whole. According to the MHLW statis- 
tics, the supply of care services expanded after implementing the insurance 
system. However, the effects of market-oriented reform on service quality 
and efficiency are unknown. It is unknown, for example, whether intro- 10  David A. Wise 
ducing competition by expanding the number of providers in an area can 
simultaneously improve the quality of service and management efficiency. 
Zhou and Suzuki use cross-sectional data to investigate the effect of 
market concentration on the quality and cost of home help services. They 
focus on home help services because the reforms in this market have been 
dramatic, and the proportion of for-profit providers is one of the highest 
among the at-home nursing care businesses. The number of home help ser- 
vice care providers per thousand elderly is used as an index of market con- 
centration. To evaluate the impact of market-oriented reform on service 
quality and efficiency, the authors consider whether care providers in un- 
concentrated (ie., highly competitive) markets have a higher level of qual- 
ity and efficiency than those in highly concentrated markets. The authors 
note that this information is also helpful for determining the appropriate 
number and scale of operations of care providers in each district. 
According to the Survey of Nursing Care Management (Kaigo Jigyo 
Keei Jita Chosa) 2002 by MHLW, the higher the market competition (or, 
the fewer users per care facility), the higher the costs per care plan. This 
suggests that competition among care providers may lead to higher man- 
agement costs, which is reminiscent of the “medical arms race hypothesis” 
in hospital industry research. The paper shows that this finding does not 
hold in the context of the home health industry when an appropriate econo- 
metric framework is used to control for the effect of other related factors 
such as the quality of service. 
The major findings are (a) holding constant the scale of operations, re- 
gion, and ownership, there is a positive relationship between market com- 
petition and quality of services only in the case of information services. 
This result shows that the impact of market competition on the quality of 
care service, if any, was quite limited in 2000, (b) contrary to the impression 
created by the descriptive results from the survey by MHLW, this analysis 
shows that competition is associated with lower costs. In other words, mar- 
ket competition induces cost savings in the home help care market, and (c) 
there is a tradeoff between quality and cost; running a subsidiary business 
has few cost-saving premiums; branch offices have lower costs than head- 
quarters; and new providers and nonprofit providers incur higher costs 
than their counterparts. 
The authors caution against generalizing their findings beyond the home 
help business, but find foundation for the concern that market-oriented re- 
forms will sacrifice quality in the name of cost savings. 
In “A Comparison of the Quality of Health Care in the United States 
and Japan: Treatment and Outcomes for Heart Attack Patients,” Haruko 
Noguchi, Yuichiro Masuda, Masafumi Kuzuya, Akihiko Iguchi, Jeffery 
Geppert, and Mark McClellan consider differences in treatment patterns 
and the relationship between treatment patterns and health care quality 
among AM1 patients in the two countries. Introduction  11 
Heart disease is the leading cause of death in the United States, and 
AMIs are directly or indirectly responsible for most of these deaths. In 
Japan, as in the United States, heart disease has become one of the signifi- 
cant causes of death. Perhaps more than one-third of those with heart dis- 
eases died of AM1 in 1998. Though death from AM1 remains less common 
in Japan than in the United States, the increasing incidence of AM1 and the 
overall aging of Japanese society suggests that heart attacks may become a 
significant health problem in the future, much as cancer is now. 
This study had several main objectives. The first was to create a data set 
containing information on treatments and outcomes among AM1 patients 
in Japan, comparable to the Cooperative Cardiovascular Project (CCP) in 
the United States. The second objective was to investigate variation be- 
tween the United States and Japan in the quality of health care for elderly 
patients (age sixty-five or over) with AMI, with respect to treatments and 
outcomes and controlling for chart-based detailed clinical information. 
In this study, the authors divide medical procedures performed on AM1 
patients  into high-tech and low-tech treatments.  They define high-tech 
treatments as those with large fixed or marginal costs and low-tech treat- 
ments as those with relatively low fixed and marginal costs. Low-tech treat- 
ments, in principle, could be provided by  virtually any medical facility. 
Both types of procedures are used widely enough to contribute substan- 
tially to patient outcomes and hospital expenditure. 
The main conclusions are as follows. First, among elderly AM1 patients 
the authors find significant heterogeneity both in the presence of comorbid 
conditions and also in the treatments received. This heterogeneity under- 
scores the importance of utilizing a richly detailed data set when perform- 
ing an observational analysis focusing on health outcomes. Second, after 
adjusting for chart-based patient characteristics and treatments received, 
the authors observe that high-tech treatments contribute significantly to 
improved patient outcomes and to increased hospital expenditure, but that 
the effects are much larger for the CCP than Japanese patients. Third, the 
aggressive use of intensive treatments soon after admission tends to im- 
prove patient outcomes in the short term, while it may lead to increased 
risks in the longer term. Fourth, a CCP patient who undergoes an intensive 
procedure tends to stay in the hospital longer compared to the one who 
does not, while a patient in Japan tends to have a shorter hospital stay, be- 
fore and after, controlling for various characteristics. Finally, the CCP pa- 
tients are more aggressively treated by beta-blocker use and smoking ces- 
sation than Japanese patients, but the authors observe that collaborative 
medical centers in the Japanese data tend to perform intensive procedures 
more often. 
In  “Geography and the Use  of  Effective Health Care in the United 
States,” Jonathan Skinner focuses on the variation in medical practice pat- 
terns across geographic regions of the United States. There is a growing 12  David A. Wise 
concern in the United States about shortfalls in health care quality. There 
are a wide variety of procedures that are proven to be effective yet are of- 
ten used at rates as low as 50 percent. Examples of such effective treatments 
include the use of beta-blockers and aspirin for appropriate heart attack 
patients, annual eye examinations for people with diabetes, and mammog- 
raphy examinations for women over age fifty. On the other hand, there is 
evidence of overuse of procedures where they are not appropriate. For ex- 
ample, 20 percent of antibiotics prescribed in 1992 were used for common 
colds and respiratory tract infections, illnesses where the effectiveness of 
such antibiotics is questionable and may even be harmful. Only about one- 
third of angioplasties (PTCA) for cardiovascular disease are clearly ap- 
propriate, with about one-half uncertain and the remainder inappropriate. 
Technological advances in diagnostic methods to detect appendicitis, such 
as computerized tomography, have improved tremendously, but there has 
been no apparent decline in the rate of inappropriate surgery. 
Skinner focuses on the underuse of effective procedures and, in particu- 
lar, the remarkable variation across regions in the United States with re- 
gard to the use of such treatments. Geographical variation in quality of 
care is of interest for two reasons. First, it provides a snapshot of the degree 
of technological inefficiency  in the health care system, that is, how much do 
some regions and hospitals lag behind best-practices available in other ar- 
eas? It is not surprising that health care innovations take time to diffuse; 
physicians need to be  trained  in  the  use  of  new  technology  (perhaps 
through residency programs), and their use spreads as the newly trained 
residents diffuse to new practice areas. What is more surprising is the per- 
sistence of shortfalls in quality across regions. 
To  quantify  the degree of  technological “process” inefficiency in the 
United States, Skinner uses data from the Dartmouth Cardiovascular Atlas 
of Healthcare (2000)  that, in turn, is based on a large detailed survey (with 
chart reviews) of more than 160,000 heart attack patients during 1994 and 
1995. He finds that the average loss per heart attack patient, relative to 
best-practice care, is between $1,500 and $5,000 per year, depending on the 
benchmark used, the value of a life-year, and other assumptions. The mea- 
sured inefficiency does not stem from specific skills of the surgeon, but in- 
stead largely reflects the use (or nonuse) of pharmaceuticals such as beta- 
blockers and aspirin. 
Geographic variation is then used to estimate a reduced form model of 
technology adoption that depends on “supply” factors that might be ex- 
pected to lower the cost of adapting the new technology, such as the preva- 
lence of cardiologists-who  are presumably most aware of new technol- 
ogies in the use of health care innovations-and  “demand” factors such as 
education, income, and the overall incidence of heart disease in the region. 
The author finds that supply factors are less important in explaining tech- 
nology diffusion than expected, but estimated demand effects are signifi- Introduction  13 
cant both statistically and economically. More cardiologists per capita is 
not significantly associated with higher rates of beta-blocker use, nor is 
there an association between cardiologist supply and the average quality 
use rate for beta-blockers, aspirin, reperfusion, and angiotensin converting 
enzyme (ACE) inhibitors. 
In conclusion, the author says, there seems to be a missing link between 
the potentially large benefits of effective care for heart attack patients and 
financial incentives to pay for them. While beta-blockers may not be reim- 
bursed directly by the Medicare program (and indeed cost just pennies per 
dose), other procedures with uncertain (or potentially negative) effects on 
outcomes, such as nonprimary angioplasty, or angioplasty for non-Q-wave 
heart attacks, are paid in full by Medicare. An intriguing question that re- 
mains is why physicians working in hospital settings do not comply with 
quality guidelines, given the large benefits in terms of patient outcomes. 
Given the significant variation in medical treatment patterns and the 
geographic variation from best-practices-even  within the health care sys- 
tem of one country-continued  research on the differences in health care 
across countries would seem extremely valuable in assessing and improv- 
ing quality in all countries. 
Other Topics in Health Care 
The final two chapters of the volume deal with selected other issues in 
health care in Japan and the United States. In “Does Caregiving Affect 
Work? Evidence Based on Prior Labor Force Experience,,’ Kathleen Mc- 
Carry assesses the impact of caregiving on the labor force behavior of 
women. The United States General Accounting Office estimates that by 
2040 there could be as many as 12 million disabled elderly. Based on cur- 
rent caregiving patterns, the vast majority of these needy individuals will 
receive care exclusively through informal networks of family and friends, 
most typically a spouse or child. Intuitively one would expect this caregiv- 
ing to affect the labor market behavior of the provider; caregivers may re- 
duce hours or exit employment entirely in response to the needs of an el- 
derly family member. On an individual level, reductions in labor market 
activity would be expected to affect later financial well-being. Not only 
would there be the obvious decline in earnings and thus an expected de- 
cline in retirement savings, but also future pension benefits may be ad- 
versely affected as well. These adverse effects may be especially severe for 
women as they comprise the majority of caregivers and, perhaps for this 
reason, the majority of poor elderly. 
However, it is not clear whether those who provide care do so because 
they are working fewer hours, or if they work fewer hours because of their 
caregiving chores. McGarry takes advantage of a longitudinal panel of ob- 
servations on employment and caregiving to begin to address this issue. 14  David A. Wise 
She examines labor market behavior prior to caregiving and notes how it 
differs for those who subsequently provide care and those who do not. She 
looks both at short-term effects through changes in behavior over a two- 
year period and at more extended effects over a period of six years. Her 
measures of labor market attachment include employment status, hours 
worked, and expected retirement. 
She finds surprisingly little relationship between previous employment 
and later caregiving. The results of her multivariate analysis show little re- 
lationship between labor market ties and caregiving later in life. Having a 
parent who needs care does not affect employment behavior, and lagged la- 
bor force participation does not affect current caregiving. 
In “Conjoint Analysis to Estimate the Demand for Nicotine Replace- 
ment Therapy in Japan,” Seiritsu Ogura, Wataru Suzuki, Makoto Kawa- 
mura, and Tamotsu Kadoda consider the demand for nicotine gum. Ciga- 
rette smoking is associated with such life-threatening illnesses as cancer, 
ischemic heart disease, cerebrovascular disease, and chronic lung disease. 
Passive smoking is also a risk factor for such diseases, and cigarette smok- 
ing is one of the most serious causes of premature mortality in Japan. It is 
estimated that about 95,000 Japanese die annually due to smoking-related 
illnesses, accounting for 12 percent of total deaths. Estimates of the annual 
medical cost due to smoking-related disease range from 5 to 15 percent of 
national medical expenditures. 
In response to escalating national health care costs, particularly those of 
lifestyle-related diseases, smoking cessation has become one of the most 
important national health policy objectives. The MHLW established the 
“Committee on Tobacco Control for the 21st Century” in the year 2000 
and was committed to a national no-smoking-week campaign. The min- 
istry also established as an objective the provision of support to help smok- 
ers in all communities to stop smoking. The Japanese Medical Association 
has also conducted an antismoking campaign since 2001. 
A significant proportion of smokers seriously consider quitting smok- 
ing. For example, according to the 1998 Survey on Smoking and Health 
Problems conducted by the Japanese government, 26.7 percent of current 
smokers aged fifteen and over want to quit smoking, and 64.2 percent of 
them want to quit smoking or reduce smoking. However, only a small frac- 
tion of them actually succeed on their own. Recently, however, smoking in- 
tervention programs, particularly those using nicotine replacement ther- 
apy (NRT), have been shown to be effective in other countries, such as the 
United States. 
Nicotine replacement therapy is a method of treatment that helps smok- 
ers by alleviating the withdrawal symptoms associated with smoking ces- 
sation by replacing the nicotine. Two types of NRT products are available 
in Japan: nicotine transdermal patches and nicotine gum. Nicotine patches 
were approved by the MHLW in 1994, and nicotine gums were approved in Introduction  15 
1999. Despite the effectiveness of the products, they failed to come into 
wide use in Japan as they were available only by prescription,  and their 
costs were not covered by the public health insurance. 
In September 2001, the MHLW approved nicotine gum (brand name 
Nicorette) as an over-the-counter drug. There immediately followed an ex- 
tensive national campaign by the pharmaceutical company using TV, news- 
papers, and magazines. As a result, Nicorette is now widely recognized 
among smokers as well as nonsmokers. 
In this paper, Ogura, Suzuki, Kawamura, and Kadoda estimate the de- 
mand for nicotine gum and examine the smoking cessation assistance pol- 
icy with NRT using original survey data they gathered in late 2001. Their 
analysis is based on conjoint analysis (CA), a technique that is relatively 
new to the field of health economics. 
Conjoint analysis is one of the techniques belonging to contingent Val- 
uation methods (CVM) used  to estimate an individual’s utilities from 
various choices, based on responses to hypothetical questions. Conjoint 
analysis was  originally developed in  the field  of market  research  and 
psychometrics. It has been widely used in environmental economics and 
transportation  economics, and it has been introduced  into health  eco- 
nomics. In Japan, CA has been used to estimate the demand for nursing, 
the choice of medical facilities, and the demand for medical care for minor 
illness. 
The estimates obtained from conjoint analysis indicate that a 10,000 yen 
decrease in the price of nicotine gum (a price reduction of about 30 per- 
cent) would increase its demand by  16.5 percent, and a 100 yen increase in 
the price of cigarettes (a price increase of about 40 percent) would lead to 
an increase of 4.2 percent in the demand for nicotine gum. The analysis 
also revealed that if nicotine gum were sold from vending machines or con- 
venience stores, its demand would increase by 3.3 percent. A cost-benefit 
analysis was conducted to estimate the consequence of a subsidy policy for 
nicotine gum. A 70 percent subsidy for the nicotine gum would cost the 
government 352.4 billion yen. The benefit of such a subsidy would be the 
reduction in smoking-related illnesses through successful smoking cessa- 
tion. This would reduce annual medical insurance benefits by 67.6 billion 
yen. In five years, therefore, the government would be able to save 338.5 bil- 
lion yen-almost  equal to the cost of  the original subsidy. A national 
health promotion program called Healthy Japan 2 1, established by  the 
MHLW in 2000, established smoking cessation promotion as one of the 
most important policy objectives. The authors conclude that a subsidy for 
nicotine gum or insurance coverage for the gum could be  a means of 
achieving that goal. This Page Intentionally Left Blank